Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 31 articles:
HTML format
Text format



Single Articles


    September 2017
  1. NEUZILLET Y, Chapeaublanc E, Krucker C, De Koning L, et al
    IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.
    BMC Cancer. 2017;17:636.
    PubMed     Text format     Abstract available


    June 2017
  2. PENG D, Gong YQ, Hao H, He ZS, et al
    Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    BMC Cancer. 2017;17:391.
    PubMed     Text format     Abstract available


    May 2017
  3. TEYSSONNEAU D, Daste A, Dousset V, Hoepffner JL, et al
    Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
    BMC Cancer. 2017;17:323.
    PubMed     Text format     Abstract available


  4. FONTEYNE V, Dirix P, Junius S, Rammant E, et al
    Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
    BMC Cancer. 2017;17:308.
    PubMed     Text format     Abstract available


    April 2017
  5. KAO YT, Wu CH, Wu SY, Lan SH, et al
    Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
    BMC Cancer. 2017;17:277.
    PubMed     Text format     Abstract available


  6. LAVERY HJ, Zaharieva B, McFaddin A, Heerema N, et al
    A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.
    BMC Cancer. 2017;17:247.
    PubMed     Text format     Abstract available


    March 2017
  7. MIYAKE M, Morizawa Y, Hori S, Marugami N, et al
    Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    BMC Cancer. 2017;17:237.
    PubMed     Text format     Abstract available


    February 2017
  8. DYSHLOVOY SA, Madanchi R, Hauschild J, Otte K, et al
    The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
    BMC Cancer. 2017;17:93.
    PubMed     Text format     Abstract available


    January 2017
  9. BAI Y, Wang X, Yang Y, Tang Y, et al
    Parity and bladder cancer risk: a dose-response meta-analysis.
    BMC Cancer. 2017;17:31.
    PubMed     Text format     Abstract available


    November 2016
  10. KONG C, Zhan B, Piao C, Zhang Z, et al
    Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice.
    BMC Cancer. 2016;16:892.
    PubMed     Text format     Abstract available


  11. BENHAMOU S, Bonastre J, Groussard K, Radvanyi F, et al
    A prospective multicenter study on bladder cancer: the COBLAnCE cohort.
    BMC Cancer. 2016;16:837.
    PubMed     Text format     Abstract available


    January 2016
  12. KAWAHARA T, Furuya K, Nakamura M, Sakamaki K, et al
    Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
    BMC Cancer. 2016;16:185.
    PubMed     Text format     Abstract available


  13. LOPEZ DE MATURANA E, Picornell A, Masson-Lecomte A, Kogevinas M, et al
    Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.
    BMC Cancer. 2016;16:351.
    PubMed     Text format     Abstract available


  14. GARCIA PV, Seiva FR, Carniato AP, de Mello Junior W, et al
    Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.
    BMC Cancer. 2016;16:422.
    PubMed     Text format     Abstract available


  15. LI X, Wang H, Wang J, Chen Y, et al
    Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    BMC Cancer. 2016;16:578.
    PubMed     Text format     Abstract available


  16. OLDENBURG D, Ru Y, Weinhaus B, Cash S, et al
    CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
    BMC Cancer. 2016;16:713.
    PubMed     Text format     Abstract available


  17. ROPERCH JP, Grandchamp B, Desgrandchamps F, Mongiat-Artus P, et al
    Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    BMC Cancer. 2016;16:704.
    PubMed     Text format     Abstract available


  18. ANANTHARAMAN A, Friedlander T, Lu D, Krupa R, et al
    Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
    BMC Cancer. 2016;16:744.
    PubMed     Text format     Abstract available


    January 2015
  19. ZHOU B, Zhang P, Tang T, Liao H, et al
    Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
    BMC Cancer. 2015;15:433.
    PubMed     Text format     Abstract available


  20. HAYNE D, Stockler M, McCombie SP, Chalasani V, et al
    BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301).
    BMC Cancer. 2015;15:432.
    PubMed     Text format     Abstract available


  21. KU JH, Kang M, Kim HS, Jeong CW, et al
    Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.
    BMC Cancer. 2015;15:447.
    PubMed     Text format     Abstract available


  22. LEE JY, Cho KS, Kang DH, Jung HD, et al
    A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.
    BMC Cancer. 2015;15:566.
    PubMed     Text format     Abstract available


  23. ACAR O, Ozkurt E, Demir G, Sarac H, et al
    Determining the origin of synchronous multifocal bladder cancer by exome sequencing.
    BMC Cancer. 2015;15:871.
    PubMed     Text format     Abstract available


  24. SMOLENSKY D, Rathore K, Cekanova M
    Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    BMC Cancer. 2015;15:927.
    PubMed     Text format     Abstract available


  25. KIM M, Jeong CW, Kwak C, Kim HH, et al
    Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.
    BMC Cancer. 2015;15:149.
    PubMed     Text format     Abstract available


  26. YEH HH, Tseng YF, Hsu YC, Lan SH, et al
    Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
    BMC Cancer. 2015;15:172.
    PubMed     Text format     Abstract available


  27. DORES GM, Qubaiah O, Mody A, Ghabach B, et al
    A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010.
    BMC Cancer. 2015;15:185.
    PubMed     Text format     Abstract available


  28. LIU W, Qi L, Lv H, Zu X, et al
    MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.
    BMC Cancer. 2015;15:92.
    PubMed     Text format     Abstract available


  29. RETZ M, de Geeter P, Goebell PJ, Matz U, et al
    Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.
    BMC Cancer. 2015;15:455.
    PubMed     Text format     Abstract available


    January 2014
  30. CASTELLANO D, Puente J, de Velasco G, Chirivella I, et al
    Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
    BMC Cancer. 2014;14:779.
    PubMed     Text format     Abstract available


  31. GREIFE A, Jankowiak S, Steinbring J, Nikpour P, et al
    Canonical Notch signalling is inactive in urothelial carcinoma.
    BMC Cancer. 2014;14:628.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: